PROLEUKIN Trademark

Trademark Overview

On Tuesday, July 8, 2014, a trademark application was filed for PROLEUKIN with the United States Patent and Trademark Office. The USPTO has given the PROLEUKIN trademark a serial number of 86330987. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, June 16, 2025. This trademark is owned by Novartis Vaccines & Diagnostics, Inc.. The PROLEUKIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases and disorders
proleukin

General Information

Serial Number86330987
Word MarkPROLEUKIN
Filing DateTuesday, July 8, 2014
Status800 - REGISTERED AND RENEWED
Status DateMonday, June 16, 2025
Registration Number4761828
Registration DateTuesday, June 23, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 13, 2015

Trademark Statements

Description of MarkThe mark consists of the word "PROLEUKIN" preceded by a sphere formed by two swirls; the color gray is intended to show shading or contrast only.
Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 11, 2014
Primary Code005
First Use Anywhere DateMonday, February 2, 2015
First Use In Commerce DateMonday, February 2, 2015

Trademark Owner History

Party NameIOVANCE BIOTHERAPEUTICS MANUFACTURING LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressPHILADELPHIA, PA 19112
Party NameCLINIGEN HOLDINGS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type11 - Company
AddressSTAFFORDSHIRE DE142WW
GB
Party NameNovartis Vaccines & Diagnostics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameNovartis Vaccines & Diagnostics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameNovartis Vaccines & Diagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Wednesday, October 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 11, 2014NEW APPLICATION ENTERED
Friday, July 11, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 12, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, October 20, 2014ASSIGNED TO EXAMINER
Friday, May 1, 2015SU - NON-FINAL ACTION - WRITTEN
Tuesday, November 11, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, December 24, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 13, 2015PUBLISHED FOR OPPOSITION
Tuesday, January 13, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, March 10, 2015USE AMENDMENT FILED
Monday, April 13, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 10, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 13, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 1, 2015NON-FINAL ACTION E-MAILED
Friday, May 1, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 23, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 19, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 21, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 22, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 23, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, December 11, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, August 27, 2020TEAS SECTION 8 & 15 RECEIVED
Thursday, January 9, 2025TEAS SECTION 8 & 9 RECEIVED
Monday, June 16, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 16, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, June 16, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, October 14, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 14, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 14, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, February 7, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, June 23, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, June 16, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

proleukin diseases disorders oncological treatment preparations pharmaceutical